Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol
Article in Advanced Therapeutics (September 2020)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Inhibition of ERα/ERK/P62 cascades induces “autophagic switch” in the estrogen receptor-positive breast cancer cells exposed to gemcitabine
Article in Oncotarget (July 2016)
Triple-negative breast cancer: investigating potential molecular therapeutic target
Article in Expert Opinion on Therapeutic Targets (October 2014)